Envista Holdings

NVST US Health Care Health Care Supplies
S&P 400
$25.55
-1.24%
Delayed · cached 15 min

Fair value analysis

NVST
Envista Holdings
Health CareHealth Care Supplies
$25.55
Close used for this calculation
$15.83Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
40/100
Profitability14/25
Returns3/25
Balance Sheet21/25
Efficiency2/25
Growth12/25
Average
Quality radar
40Prof.14/25Ret.3/25Eff.2/25B.Sht21/25Growth12/25

Consensus fair value

$15.83
Above FV
▼ -38.0% against the close used
Model range $2.87 – $25.73
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear$2.87Fair value$15.83Bull$25.73
FairClose
52-week traded range
52W low $18.9552W high $30.26

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

Envista Holdings closed at $25.55, 61.4% above the consensus fair value of $15.83 drawn from 8 valuation models.

Financial DNA score 40/100 — Average. P/E of 91.3x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
$25.73
+0.7%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=8%, r=10%, tg=3%, n=10yr
Graham Number
$10.88
-57.4%
√(22.5 × EPS × BVPS)
EPS=0.28, BVPS=18.79 · outside Graham range (P/E 91.3, P/B 1.4) — asset-light, treat as a rough floor
P/E Fair Value
$5.60
-78.1%
EPS × 20x (sector P/E)
EPS=0.28, Sector P/E=20x
Peter Lynch (PEG)
$8.36
-67.3%
EPS × Growth% (PEG = 1 is fair)
EPS=0.28, g=29.9%
EV/EBITDA
$18.38
-28.1%
(EBITDA × 10x − Net Debt) ÷ Shares
EBITDA=332.1M
Book Value (P/B)
$2.87
-88.8%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=18.79, ROE=1.5%, g=3%, r=10%
Reverse DCF
$25.55
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 27.8% | Historical: -29.9%
Margin of Safety
$10.55
-58.7%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=14.07, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.